Edgewise Therapeutics, Inc. — Director's Dealing 2021

Mar 26, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Edgewise Therapeutics, Inc. (EWTX)
CIK: 0001710072
Period of Report: 2021-03-25

Reporting Person: KOCH KEVIN (Director, President and CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	259554	Indirect
Common Stock	26410	Indirect
Common Stock	26410	Indirect
Common Stock	26410	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$0.18	2027-08-08	Common Stock (51180)		Direct
Stock Option (Right to Buy)	$0.45	2028-11-15	Common Stock (178710)		Direct
Stock Option (Right to Buy)	$0.64	2029-11-14	Common Stock (491864)		Direct
Stock Option (Right to Buy)	$0.71	2030-09-01	Common Stock (380274)		Direct
Stock Option (Right to Buy)	$1.93	2030-12-15	Common Stock (664292)		Direct

Footnotes

F1: These shares are held directly by the KTK Family Enterprise, LLC for the which the Reporting Person serves as Manager.

F2: These shares are held directly by the Adrienne R. Koch Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.

F3: These shares are held directly by the Matthew K. Koch Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.

F4: These shares are held directly by the Nicole M. Soldow Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.

F5: 1/48th of the shares subject to the option became vested and exercisable on July 13, 2017 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.

F6: 1/4th of the shares subject to the option became vested and exercisable on November 2, 2019 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.

F7: 1/48th of the shares subject to the option became vested and exercisable on November 16, 2019 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.

F8: 1/48th of the shares subject to the option became vested and exercisable on October 2, 2020 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.

F9: 1/48th of the shares subject to the option became vested and exercisable on January 3, 2021 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.